416 related articles for article (PubMed ID: 20121555)
1. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M
Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555
[TBL] [Abstract][Full Text] [Related]
2. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
3. Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.
Quintero V; Garcia-Pose A; Barrios-Tascon A; Pacheco-Cumani M
J Pediatr Hematol Oncol; 2014 Nov; 36(8):653-5. PubMed ID: 24942015
[TBL] [Abstract][Full Text] [Related]
4. Current insight into thrombotic thrombocytopenic purpura.
Verbeke L; Delforge M; Dierickx D
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
Thomas MR; de Groot R; Scully MA; Crawley JT
EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
[TBL] [Abstract][Full Text] [Related]
6. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR
Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
[No Abstract] [Full Text] [Related]
7. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura in IgG4-related disease with severe deficiency of ADAMTS-13 activity and IgG4 autoantibody against ADAMTS-13.
Saeki T; Ito T; Youkou A; Ishiguro H; Sato N; Yamazaki H; Koike T; Kourakata H; Ferrari S; Scheiflinger F; Narita I
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1209-12. PubMed ID: 21523922
[No Abstract] [Full Text] [Related]
9. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
Hagel S; Jantsch J; Budde U; Kalden JR; Eckardt KU; Veelken R
Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551
[No Abstract] [Full Text] [Related]
12. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga J; Studt JD; Mansouri Taleghani B; Alberio L
Hematol J; 2004; 5 Suppl 3():S6-11. PubMed ID: 15190269
[No Abstract] [Full Text] [Related]
13. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y
Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Sadler JE
Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
Jian C; Xiao J; Gong L; Skipwith CG; Jin SY; Kwaan HC; Zheng XL
Blood; 2012 Apr; 119(16):3836-43. PubMed ID: 22289888
[TBL] [Abstract][Full Text] [Related]
17. Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients.
Watanaboonyongcharoen P; Whinna HC; Park YA
J Clin Apher; 2014 Dec; 29(6):336-8. PubMed ID: 24764259
[TBL] [Abstract][Full Text] [Related]
18. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
Matsumoto M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
[TBL] [Abstract][Full Text] [Related]
19. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
Starke R; Machin S; Scully M; Purdy G; Mackie I
Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
[TBL] [Abstract][Full Text] [Related]
20. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.
George JN; Chen Q; Deford CC; Al-Nouri Z
J Clin Apher; 2012; 27(6):302-11. PubMed ID: 22927184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
